Yield of a multiplexed gastrointestinal polymerase chain reaction panel for evaluation of diarrhea in hospitalized patients with cancer: a diagnostic stewardship opportunity
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 12.11.2026. Verfasst von Emily A. Rosen und 16 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Multiplexed polymerase chain reaction gastrointestinal panels (GIPs) include mostly community-acquired pathogens. Diagnostic yield of GIPs for detection of non- Clostridioides difficile targets in hospitalized patients with cancer with community versus hospital-onset diarrhea is not well defined.
Methods
This cross-sectional study included stool tests from hospitalized adults with a cancer diagnosis from July 2021 to May 2025. Our center recommends a GIP primarily for patients with community-onset diarrhea and stand-alone C. difficile testing for hospital-onset diarrhea. Generalized estimating equations with Poisson regression were used to estimate the prevalence ratio (PR) of detecting ≥1 non- C. difficile target after hospital day (HD) 3 compared to HD 1–3.
Results
Among 1,433 GIPs from 1,127 patients, 468 (33%) were ordered after HD 3. Most GIPs were among patients with hematologic malignancies (794/1,433; 55%) and of those tests 352/794 (44%) were ordered after HD 3. Among all GIPs, C. difficile and norovirus were detected most frequently (16% and 6%, respectively). A non- C. difficile target was detected after HD 3 on 49/468 GIPs (10%), compared to 146/965 (15%) GIPs on HD 1–3 (adjusted PR 0.73; 95% CI [0.53–1.00]; P = .053). Among 49 GIPs after HD 3 detecting ≥1 non- C. difficile target, 19 tests were ordered for new-onset diarrhea and only 5 of these patients received intentional antimicrobial therapy in response to the GIP result.
Conclusions
The added diagnostic yield for detecting ≥1 non- C. difficile target by GIP in patients with cancer and hospital-onset diarrhea is limited and supports restricting GIP ordering after HD 3 on oncology units.
Zitieren
APA
Rosen, E. A., Truong, S., Krantz, E. M., Thibodeau, A., Wallace, C. K., Escobar, Z. K., Bhattacharyya, P., Lengermann, R., Swetky, M., Walji, S., Wilson, M. H., Bourassa, L., Olson, S., Lang, J., Oshima, M. U., Pergam, S. A., & Liu, C. (2026). Yield of a multiplexed gastrointestinal polymerase chain reaction panel for evaluation of diarrhea in hospitalized patients with cancer: a diagnostic stewardship opportunity. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10949
Vancouver
Rosen EA, Truong S, Krantz EM, Thibodeau A, Wallace CK, Escobar ZK, et al. Yield of a multiplexed gastrointestinal polymerase chain reaction panel for evaluation of diarrhea in hospitalized patients with cancer: a diagnostic stewardship opportunity. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10949
BibTeX
@article{Rosen2026,
author = {Rosen, Emily A. and Truong, Shandra and Krantz, Elizabeth M. and Thibodeau, Allison and Wallace, Cynthia K. and Escobar, Zahra Kassamali and Bhattacharyya, Pooja and Lengermann, Regina and Swetky, Michelle and Walji, Salma and Wilson, Marie H. and Bourassa, Lori and Olson, Sandra and Lang, Joanne and Oshima, Masumi Ueda and Pergam, Steven A. and Liu, Catherine},
title = {Yield of a multiplexed gastrointestinal polymerase chain reaction panel for evaluation of diarrhea in hospitalized patients with cancer: a diagnostic stewardship opportunity},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10949}
}
EUVIMED